Peer-reviewedCC BY 4.0eClinicalMedicine
Efficacy and safety of oxfendazole in adults with Trichuris spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial
Related
- Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
- Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial
- Efficacy and safety of erythrocytapheresis in chronic mountain sickness: a randomised controlled trial protocol (ESCAPE-CMS)
- Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies
- Safety and efficacy of levacetylleucine in ataxia-telangiectasia: a phase 3, randomised, double-blind, placebo-controlled crossover trial
BibTeX
@article{schnoz2026efficacy,
title = {{Efficacy and safety of oxfendazole in adults with Trichuris spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial}},
author = {Annina Schnoz and Hannah Jeanguenat and Abrahaman S. Msellem and Ibrahim S. Mohammed and Ramadhan S. Abdalla and Salum N. Seif and Amour K. Amour and Mahdi J. Khamis and Fabrice L. Mougeni and Oleksandr Volotko and Olga Sieradzan and Karen Dequatre Cheeseman and George M. Nyangweso and Thaddaeus W. Egondi and Fabiana Barreira and Marc P. Hübner and Sonja Zehetmayer and Said M. Ali and Jennifer Keiser},
journal = {eClinicalMedicine},
year = {2026},
month = oct,
doi = {10.1016/j.eclinm.2026.104273},
url = {https://linkinghub.elsevier.com/retrieve/pii/S2589537026005262},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Efficacy and safety of oxfendazole in adults with Trichuris spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial
AU - Annina Schnoz
AU - Hannah Jeanguenat
AU - Abrahaman S. Msellem
AU - Ibrahim S. Mohammed
AU - Ramadhan S. Abdalla
AU - Salum N. Seif
AU - Amour K. Amour
AU - Mahdi J. Khamis
AU - Fabrice L. Mougeni
AU - Oleksandr Volotko
AU - Olga Sieradzan
AU - Karen Dequatre Cheeseman
AU - George M. Nyangweso
AU - Thaddaeus W. Egondi
AU - Fabiana Barreira
AU - Marc P. Hübner
AU - Sonja Zehetmayer
AU - Said M. Ali
AU - Jennifer Keiser
PY - 2026
DA - 2026/10/30
JO - eClinicalMedicine
DO - 10.1016/j.eclinm.2026.104273
UR - https://linkinghub.elsevier.com/retrieve/pii/S2589537026005262
SN - 2589-5370
ER -